Banxia xiexin decoction prevents the development of gastric cancer

Table 4 mRNA expression content in the phosphoinositide 3-kinase/protein kinase B signaling pathway (mean ± SD)

Group	EGFR	PIK3CA	AKT1	IL6	BCL2
Model	1.00 ± 0.1	0.80 ± 0.25	1.01 ± 0.11	1.56 ± 0.06	2.23 ± 0.52
Capecitabine	0.97 ± 0.4	0.34 ± 0.17a	0.07 ± 0.04b	1.01 ± 0.14b	0.52 ± 0.13b
BXD	0.79 ± 0.39a	0.41 ± 0.18	0.04 ± 0.01b	1.52 ± 0.25	1.09 ± 0.56a
LY294002	0.25 ± 0.14b	0.07 ± 0.02b	0.09 ± 0.05b	1.59 ± 0.17	0.85 ± 0.47a
BXD + LY294002	0.01 ± 0.01b	0.38 ± 0.21	0.06 ± 0.01b	0.74 ± 0.07b	0.40 ± 0.11b

^aP < 0.05.

^bP < 0.01.

BXD: Banxia xiexin decoction.